M's Science Corporation   Report issue

For profit Phase 2
Founded: Kobe Japan (2000)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2007
NCT00551109
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

cutamesine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1